MedCity News
Curebase raises $15M for decentralized clinical trials
Curebase, a startup building software for decentralized clinical trials, raised $15 million in funding. The startup ran six trials related to Covid-19 in the last year.
Shares0
After the Covid-19 pandemic put several clinical trials on hold, many companies were forced to shift to a virtual approach to resume their research. This presented an opportunity for startups providing decentralized clinical trials services, a once nascent but now booming business even CVS Health recently launched its own decentralized clinical trials unit.
Curebase, a San Francisco-based company building software for remote clinical trials, recently raised $15 million in funding.
This year, startups can apply in three categories - home health, chronic disease management and value-based care, and tech to boost payer/provider efficiency.
Developed by Noteworth, the ConnectedCare365 application will enable Geisinger clinicians to virtually monitor patient vital signs and intervene when needed. The platform will be used for several clinical initiatives, including chronic condition management and behavioral health.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.